Emerging Therapies for Critical Limb Ischemia

Emerging therapies for critical limb ischemia (CLI) aim to improve outcomes and prevent amputations in patients with severe arterial insufficiency. Innovative approaches, including stem cell therapy, gene therapy, and enhanced endovascular techniques, are being explored to promote revascularization and tissue regeneration. The use of novel devices such as drug-coated balloons and bioengineered grafts has shown promise in addressing complex lesions. Multidisciplinary care, integrating medical and surgical management, is essential for optimizing treatment strategies. As research progresses, these emerging therapies may significantly impact the clinical management of CLI, offering hope for affected patients.

    Related Conference of Emerging Therapies for Critical Limb Ischemia

    November 19-20, 2025

    7th World Heart Congress

    Tokyo, Japan
    November 24-25, 2025

    36th Annual Cardiologists Conference

    Barcelona, Spain
    November 27-28, 2025

    32nd World Heartcare Summit

    Paris, France
    January 12-13, 2026

    12th International Heart Conference

    Dubai, UAE
    March 18-19, 2026

    15th World Heart Congress

    Paris, France
    March 23-24, 2026

    41st World Cardiology Conference

    London, UK
    April 08-29, 2026

    9th Annual Heart Rhythm Conference

    Vienna, Austria
    April 13-14, 2026

    9th World Heart and Brain Conference

    Tokyo, Japan
    May 14-15, 2026

    5th International Conference on Cardiology

    Rome, Italy
    May 21-22, 2026

    15th World Congress on Cardiology

    London, UK
    July 29-30, 2026

    30th World Cardiology Conference

    Paris, France

    Emerging Therapies for Critical Limb Ischemia Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in